Daniel Swinson

The GO2 trial tested reduced intensity of chemo for pts w adv gastroesophageal cancer & found reducing intensity led to comparable survival but w improved patient experience, & decision-making can be enhanced using geriatric assessment ja.ma/2SOOXik #GeriOnc

Say it loud... Reduced dose chemotherapy is patient centred, safe and effective for patients with advanced gastric-oesophageal cancer GO2 trial

CTRad success - future’s bright

Always easier to start something.... Not so easy to stop interventions.

If you love a capella singing you’ll love this

Well done Pete - fantastic presentation dailynews.ascopubs.org/do/10.1200/ADN…